6 hours ago
1
sinology/Moment via Getty Images
- CVRx (NASDAQ:CVRX) saw a 17% increase in its shares following the announcement that Centers for Medicare and Medicaid Services (CMS) has proposed to include the Barostim implant procedure.
- The procedure is included under the New Technology Ambulatory Payment Classification 1580, which
English (US) ·